Literature DB >> 29740739

Fe(II) formation after interaction of the amyloid β-peptide with iron-storage protein ferritin.

Lucia Balejcikova1, Katarina Siposova1, Peter Kopcansky1, Ivo Safarik2,3.   

Abstract

The interaction of amyloid β-peptide (Aβ) with the iron-storage protein ferritin was studied in vitro. We have shown that Aβ during fibril formation process is able to reduce Fe(III) from the ferritin core (ferrihydrite) to Fe(II). The Aβ-mediated Fe(III) reduction yielded a two-times-higher concentration of free Fe(II) than the spontaneous formation of Fe(II) by the ferritin itself. We suggest that Aβ can also act as a ferritin-specific metallochaperone-like molecule capturing Fe(III) from the ferritin ferrihydrite core. Our observation may partially explain the formation of Fe(II)-containing minerals in human brains suffering by neurodegenerative diseases.

Entities:  

Keywords:  Alzheimer’s disease; Aβ; Ferritin; Iron reduction; Magnetite; Metallochaperone

Mesh:

Substances:

Year:  2018        PMID: 29740739      PMCID: PMC6082800          DOI: 10.1007/s10867-018-9498-3

Source DB:  PubMed          Journal:  J Biol Phys        ISSN: 0092-0606            Impact factor:   1.365


  24 in total

Review 1.  Electro-Fenton process and related electrochemical technologies based on Fenton's reaction chemistry.

Authors:  Enric Brillas; Ignasi Sirés; Mehmet A Oturan
Journal:  Chem Rev       Date:  2009-12       Impact factor: 60.622

Review 2.  Ferritin: a versatile building block for bionanotechnology.

Authors:  Günther Jutz; Patrick van Rijn; Barbara Santos Miranda; Alexander Böker
Journal:  Chem Rev       Date:  2015-02-16       Impact factor: 60.622

3.  Amyloid Aβ 42, a promoter of magnetite nanoparticle formation in Alzheimer's disease.

Authors:  Islam Bogachan Tahirbegi; Wilmer Alfonso Pardo; Margarita Alvira; Mònica Mir; Josep Samitier
Journal:  Nanotechnology       Date:  2016-10-13       Impact factor: 3.874

4.  Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease.

Authors:  O M El-Agnaf; D S Mahil; B P Patel; B M Austen
Journal:  Biochem Biophys Res Commun       Date:  2000-07-14       Impact factor: 3.575

5.  Redox cycling of iron by Abeta42.

Authors:  Ayesha Khan; Jon P Dobson; Christopher Exley
Journal:  Free Radic Biol Med       Date:  2005-10-14       Impact factor: 7.376

6.  Mechanism of thioflavin T binding to amyloid fibrils.

Authors:  Ritu Khurana; Chris Coleman; Cristian Ionescu-Zanetti; Sue A Carter; Vinay Krishna; Rajesh K Grover; Raja Roy; Shashi Singh
Journal:  J Struct Biol       Date:  2005-09       Impact factor: 2.867

Review 7.  Brain iron metabolism and its perturbation in neurological diseases.

Authors:  Robert R Crichton; David T Dexter; Roberta J Ward
Journal:  J Neural Transm (Vienna)       Date:  2010-09-01       Impact factor: 3.575

8.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

9.  Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1-42).

Authors:  J Everett; E Céspedes; L R Shelford; C Exley; J F Collingwood; J Dobson; G van der Laan; C A Jenkins; E Arenholz; N D Telling
Journal:  J R Soc Interface       Date:  2014-03-26       Impact factor: 4.118

Review 10.  Special delivery: distributing iron in the cytosol of mammalian cells.

Authors:  Caroline C Philpott; Moon-Suhn Ryu
Journal:  Front Pharmacol       Date:  2014-07-22       Impact factor: 5.810

View more
  5 in total

1.  Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment.

Authors:  Pan Chen; Melissa Totten; Ziyan Zhang; Hana Bucinca; Keith Erikson; Abel Santamaría; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2019-02-21       Impact factor: 4.618

Review 2.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

3.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 4.  Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.

Authors:  Andrew Gleason; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

Review 5.  Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications.

Authors:  Jun-Lin Liu; Yong-Gang Fan; Zheng-Sheng Yang; Zhan-You Wang; Chuang Guo
Journal:  Front Neurosci       Date:  2018-09-10       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.